Biopharmaceutical Tubing Market Analysis Report by 2021, 2028

    Biopharmaceutical Tubing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Plastic, Metal, and Silicone) and Application (Pharmaceutical {Single Use Technology, and Others, Medical Devices, Research and Development, and Others)

    Publication Month: Feb 2022 | Report Code: TIPRE00008648 | No. of Pages: 174 | Category: Medical Device | Status: Published

    The biopharmaceutical tubing market is projected to reach US$ 6,013.27 million by 2028 from US$ 3,442.82 million in 2021; it is expected to grow at a CAGR of 8.3% from 2021 to 2028.

    Biopharmaceutical tubing are specifically designed to meet critical needs of biopharmaceutical and medical industries. This tubing is produced by the extrusion process and is extensively used in drug delivery systems, feeding tubes, and peristaltic pumps as well in a wide range of minimally critical invasive applications, including stent delivery systems, cardiovascular catheters, and urological retrieval devices. Moreover, these are also used with anesthesiology and respiratory equipment, IVs, and biopharmaceutical laboratory equipment. They confer exceptional thermal, mechanical, and chemical properties.

    Strategic Insights


    The biopharmaceutical tubing market is segmented on the bases of type, application, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. The report offers insights and in-depth analysis of the market, emphasizing on parameters such as market trends, technological advancements, and market dynamics along with the analysis of competitive landscape of world’s leading market players.

    Lucrative Regions for Biopharmaceutical Tubing Market

    Lucrative Regions for Biopharmaceutical Tubing Market

    Get more information on this report :


    Market Insights

    Increasing Elderly Population Drives Biopharmaceutical Tubing Market Growth

    Increase in life expectancy is leading to rise in geriatric population in the world. According to the World Health Organization (WHO), the global population share of people with age more than 60 would nearly double from 12% in 2015 to 22% in 2050. According to the United Nation’s World Population Ageing 2017 report, in 2017, there were 962 million people with age 60 or above in the world, and the number is expected to reach ~2.1 billion by 2050. In addition, according to the US Census Bureau, the number of people in the US with age 65 and above is anticipated to grow from 46 million in 2016 to more than 98 million by 2060, their population share would grow from ~15% to ~24% during this period. According to the United Nation’s World Population Ageing 2017 report, in 2017, Europe had the highest percentage of people of age more than 60, i.e., 25%. By 2050, ~25% or more population in all regions of the world, except Africa, would be of age 60 and above. The geriatric population in the world is anticipated to reach US$ 1.4 billion, US$ 2.1 billion, and above US$ 3.1 billion by 2030, 2050, and 2100, respectively.

    This rise in the elderly population has led to an increase in the geriatric ailments, thus generating a greater demand for diagnostic equipment and drug delivery systems. It is also resulting in the spike in incidence of urological conditions that require catheterization. Medical professionals are also encouraging self-catheterization to reduce the cost and period of hospitalization as well as to avert the risk of healthcare-associated infections (HAI). Aging is also a main factor that contributes to the surge in the incidence of chronic diseases that might lead to the need for interventions that require admission to ICUs. Thus, rapid growth in the geriatric population is directly proportional to the rising demand for medical devices that incorporate tubing, drug delivery, dialysis and cardiac bypass, peristaltic pump, and sterile filling and dispensing systems, thereby driving the adoption of biopharmaceutical tubing systems.

    Rising Demand for Minimally Invasive Procedures Contributes Significantly to Market Growth

    A minimally invasive medical procedure is generally carried out by inserting a small device or an implant in body through an incision or anatomical opening. The popularity of these procedures has increased in the recent years due to the involvement of tiny incisions, faster recovery of patients, and less discomfort caused to the patients. Moreover, these procedures are also associated with benefits such as less trauma to muscles, nerves, tissues, and organs; less bleeding and scarring; and minimal injuries to tissues and less pain.

    The growing prevalence of arthritis, cancer, and cardiovascular diseases, all of which require extensive surgical treatments, has boosted demand for minimally invasive procedures. As a result, there is an enormous demand for catheters and biopharmaceutical tubing, among other components. Furthermore, biopharmaceutical tubing systems are reasonably priced and aid in time-saving procedures. For example, employing catheter tubing for cardiac and urine catheterization significantly lowers the time required for the medical or surgical operation. Therefore, the growing demand for minimally invasive medical procedures and focus on increasing the efficiency of these procedures play an important role in propelling the demand for biopharmaceutical tubing.

    Type Insights

    Based on type, the global biopharmaceutical tubing market is segmented into plastic, metal, and silicone. In 2020, the silicone segment held the largest share of the market. Moreover, the market for the silicone segment is expected to grow at the highest CAGR during 2021–2028. The biocompatibility of silicone allows it to be compatible with human tissues and body fluids, increasing its use in medical tubing. In addition to biocompatibility, high temperature and chemical resistance, mechanical strength, and electric properties are among the properties that make it a material of choice in biological applications.

    Application Insights

    Based on application, the biopharmaceutical tubing market is segmented into pharmaceutical, medical devices, research and development, and others. The pharmaceutical segment is sub segmented as single use technology and others. The pharmaceutical segment held the largest market share in 2020, and it is further expected to be the largest shareholder in the market by 2028. Liquid transfer is an essential part of pharmaceutical manufacturing processes, including the manufacturing of cough syrup and complex active pharmaceutical ingredients (APIs) such as vaccines or specific medications for cancer treatment, and the transfer process must be carried out in a highly regulated environment. Thus, with the growing emphasis on proper transfer tubing systems with escalating production capacities, the pharmaceutical industries demand ultra-pure and corrosion-resistant systems for liquid transfer that withstand harsh environment of chemicals, which is bolstering the market growth of this segment.

    Biopharmaceutical Tubing Market, by Type – 2021 and 2028

    Biopharmaceutical Tubing Market, by Type – 2021 and 2028

    Get more information on this report :


    Product launches, and mergers and acquisitions are the highly adopted strategies by the players operating in the global biopharmaceutical tubing market. A few of the recent key product developments are listed below:

    In September 2021, DuPont introduced DuPont Liveo, a new brand name for its extensive range of silicone healthcare solutions. The Liveo brand product line includes pharmaceutical tubing and overmolded assemblies for single-use systems in biopharma processing, transdermal and topical drug delivery systems, and medical adhesives, among others.

    In June 2020, Nordson acquired Fluortek, a plastic extrusion manufacturer that provides custom dimensioned tubing to the medical device industry. As Nordson Medical continues to expand its diversified product offerings, the acquisition enhances company's ability to deliver critical components for medical device innovations.

    The COVID-19 pandemic is having the mixed impact on the biopharmaceutical tubing market. Growing COVID-19 infection in people with existing medical conditions such as asthma and diabetes also influences the growth of the market. There is a rise in the demand for drug delivery devices and equipment such as nasogastric tubes, nebulizers, spacer devices, etc. Therefore, these factors are driving the demand for biopharmaceutical tubing during the forecast period. On the other hand, many countries have changed medical device regulations owing to supply chain obstruction affect negatively on biopharmaceutical tubing market.

    Biopharmaceutical Tubing – Market Segmentation

    By Type

    • Silicone
    • Plastic
    • Metal

    By Application

    • Pharmaceutical
      • Single Use Technology
      • Others
    • Medical Devices
    • Research and Development
    • Others

    By Geography

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia Pacific
    • Middle East & Africa (MEA)
      • Saudi Arabia
      • South Africa
      • UAE
      • Rest of Middle East & Africa
    • South and Central America (SCAM)
      • Brazil
      • Argentina
      • Rest of South and Central America

    Company Profiles

    • W. L. Gore and Associates, Inc.
    • Saint-Gobain Sekurit
    • Freudenberg Group
    • RAUMEDIC AG
    • TEKNI-PLEX
    • NewAge Industries, Inc.
    • Optinova
    • Zeus Industrial Products, Inc.
    • NORDSON CORPORATION
    • DuPont de Nemours, Inc.
    • Specialty Silicone Products, Inc.
    • Hoshine Silicon Industry Co., Ltd.
    • Wacker Chemie AG
    • Shin-Etsu Chemical Co., Ltd.
    • Momentive
    • Elkem ASA
    • Wacker Chemie AG

    Frequently Asked Questions

    The factors such as increasing elderly population in world and rising demand for minimally invasive procedures drive the market growth. However, the stringent regulatory framework hinders the market growth.
    The biopharmaceutical tubing market majorly consists of the players such W. L. Gore and Associates, Inc., Saint-Gobain Sekurit, Freudenberg Group, RAUMEDIC AG, TEKNI-PLEX, NewAge Industries, Inc., Optinova, Zeus Industrial Products, Inc., NORDSON CORPORATION, DuPont de Nemours, Inc., Specialty Silicone Products, Inc., Hoshine Silicon Industry Co., Ltd., Wacker Chemie AG, Shin-Etsu Chemical Co., Ltd., Momentive, Elkem ASA, Wacker Chemie AG among others.
    Biopharmaceutical tubing is specifically designed to meet critical needs of biopharmaceutical and medical industries. Biopharmaceutical tubing is produced by the extrusion process and is extensively used in drug delivery systems, feeding tubes, and peristaltic pumps. These offer exceptional thermal, mechanical, and chemical properties used in a wide range of minimally critical invasive applications, including stent delivery systems, cardiovascular catheters, and urological retrieval devices. Moreover, these are also used with anesthesiology and respiratory equipment, IVs, and biopharmaceutical laboratory equipment.
    Use of platinum-cured silicone as material of choice for biopharmaceutical tubing is likely to act as a trend the market growth in the coming years.
    Silicone segment is growing in the biopharmaceutical tubing market.
    Proliferation of healthcare sector and rise in prevalence of chronic diseases in developing countries is likely to fuel the market growth in the coming years.
    Asia-Pacific is lucrative for the biopharmaceutical tubing market.

    1. Introduction

    1.1 Scope of the Study

    1.2 The Insight Partners Research Report Guidance

    1.3 Market Segmentation

    1.3.1 Global Biopharmaceutical Tubing Market – By Type

    1.3.2 Global Biopharmaceutical Tubing Market – By Application

    1.3.3 Global Biopharmaceutical Tubing market – By Geography

    2. Biopharmaceutical Tubing Market – Key Takeaways

    3. Research Methodology

    3.1 Coverage

    3.2 Secondary Research

    3.3 Primary Research

    4. Global Biopharmaceutical Tubing Market – Market Landscape

    4.1 Overview

    4.2 PEST Analysis

    4.2.1 North America – PEST Analysis

    4.2.2 Europe – PEST Analysis

    4.2.3 Asia Pacific – PEST Analysis

    4.3 Middle East and Africa (MEA) – PEST Analysis

    4.3.1 South and Central America (SCAM) – PEST Analysis

    4.4 Expert Opinions

    5. Investment in Biopharmaceutical Tubing

    5.1 Introduction

    5.2 Investment Made by Companies

    6. Price of Overall Silicone Feedstock in Regions - Biopharmaceutical Tubing Market

    6.1 North America

    6.2 Europe

    6.3 Asia Pacific

    7. Adoption of Alternative Materials

    8. Supply Shortages Faced by the Market Participants - Biopharmaceutical Tubing Market

    8.1 Causes

    9. Price Fluctuation

    10. Total Production Capacity of Major Player -Biopharmaceutical Tubing Market

    11. Biopharmaceutical Tubing Market – Key Market Dynamics

    11.1 Drivers

    11.1.1 Increasing Elderly Population in World

    11.1.2 Rising Demand for Minimally Invasive Procedures

    11.2 Market Restraints

    11.2.1 Stringent Regulatory Framework

    11.3 Market Opportunities

    11.3.1 Proliferation of Healthcare Sector and Rise in Prevalence of Chronic Diseases in Developing Countries

    11.4 Future Trends

    11.4.1 Use of Platinum-Cured Silicone as Material of Choice for Biopharmaceutical Tubing

    11.5 Impact Analysis

    12. Biopharmaceutical Tubing Market – Global Analysis

    12.1 Global Biopharmaceutical Tubing Market Revenue Forecast And Analysis

    12.2 Global Biopharmaceutical Tubing Market, By Geography - Forecast And Analysis

    12.3 Market Positioning of Key Players

    13. Biopharmaceutical Tubing Market – Volume Analysis

    13.1.1 Global: Biopharmaceutical Tubing Market, by Volume, 2019–2028 (Million Units)

    14. Biopharmaceutical Tubing Market Analysis – By Type

    14.1 Overview

    14.2 Biopharmaceutical Tubing Market Revenue Share, by Type (2021 and 2028)

    14.3 Plastic

    14.3.1 Overview

    14.3.2 Plastic: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

    14.4 Metal

    14.4.1 Overview

    14.4.2 Metal: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

    14.5 Silicone

    14.5.1 Overview

    14.5.2 Silicone: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

    15. Biopharmaceutical Tubing Market Analysis – By Application

    15.1 Overview

    15.2 Biopharmaceutical Tubing Market Revenue Share, by Application (2021 and 2028)

    15.3 Pharmaceutical

    15.3.1 Overview

    15.3.2 Pharmaceutical: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

    15.4 Medical Devices

    15.4.1 Overview

    15.4.2 Medical Devices: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

    15.5 Research and Development

    15.5.1 Overview

    15.5.2 Research and Development: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

    15.6 Others

    15.6.1 Overview

    15.6.2 Others: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

    16. Biopharmaceutical Tubing Market – Geographic Analysis

    16.1 North America: Biopharmaceutical Tubing Market

    16.1.1 Overview

    16.1.2 North America: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.1.3 North America: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)

    16.1.4 North America: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)

    16.1.4.1 North America: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)

    16.1.5 North America: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)

    16.1.5.1 US: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.1.5.1.1 US: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.1.5.1.2 US: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)

    16.1.5.1.3 US: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)

    16.1.5.1.3.1 US: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)

    16.1.5.2 Canada: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.1.5.2.1 Canada: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.1.5.2.2 Canada: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)

    16.1.5.2.3 Canada: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)

    16.1.5.2.3.1 Canada: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)

    16.1.5.3 Mexico: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.1.5.3.1 Mexico: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.1.5.3.2 Mexico Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    16.1.5.3.3 Mexico Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    16.1.5.3.3.1 Mexico Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    16.2 Europe: Biopharmaceutical Tubing Market

    16.2.1 Overview

    16.2.2 Europe: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.2.3 Europe: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)

    16.2.4 Europe: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)

    16.2.4.1 Europe: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)

    16.2.5 Europe: Biopharmaceutical Tubing Market, by Country, 2021 & 2028(%)

    16.2.5.1 Germany: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.2.5.1.1 Germany: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.2.5.1.2 Germany: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)

    16.2.5.1.3 Germany: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)

    16.2.5.1.3.1 Germany: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)

    16.2.5.2 France: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.2.5.2.1 France: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.2.5.2.2 France: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)

    16.2.5.2.3 France: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)

    16.2.5.2.3.1 France: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)

    16.2.5.3 UK: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.2.5.3.1 UK: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.2.5.3.2 UK: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)

    16.2.5.3.3 UK: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)

    16.2.5.3.3.1 UK: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)

    16.2.5.4 Italy: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.2.5.4.1 Italy: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.2.5.4.2 Italy: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)

    16.2.5.4.3 Italy: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)

    16.2.5.4.3.1 Italy: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)

    16.2.5.5 Spain: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.2.5.5.1 Spain: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.2.5.5.2 Spain: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)

    16.2.5.5.3 Spain: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)

    16.2.5.5.3.1 Spain: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)

    16.2.5.6 Rest of Europe: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.2.5.6.1 Rest of Europe: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.2.5.6.2 Rest of Europe: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)

    16.2.5.6.3 Rest of Europe: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)

    16.2.5.6.3.1 Rest of Europe: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)

    16.3 Asia Pacific: Biopharmaceutical Tubing Market

    16.3.1 Overview

    16.3.2 Asia Pacific: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)

    16.3.3 Asia Pacific: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)

    16.3.4 Asia Pacific: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)

    16.3.4.1 Asia Pacific: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)

    16.3.5 Asia Pacific: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)

    16.3.5.1 Japan: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.3.5.1.1 Japan: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.3.5.1.2 Japan: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)

    16.3.5.1.3 Japan: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)

    16.3.5.1.3.1 Japan: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)

    16.3.5.2 China: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.3.5.2.1 China: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.3.5.2.2 China: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)

    16.3.5.2.3 China: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)

    16.3.5.2.3.1 China: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)

    16.3.5.3 India: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.3.5.3.1 India: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.3.5.3.2 India: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)

    16.3.5.3.3 India: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)

    16.3.5.3.3.1 India: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)

    16.3.5.4 South Korea: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.3.5.4.1 South Korea: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.3.5.4.2 South Korea: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)

    16.3.5.4.3 South Korea: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)

    16.3.5.4.3.1 South Korea: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)

    16.3.5.5 Australia: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.3.5.5.1 Australia: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.3.5.5.2 Australia: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)

    16.3.5.5.3 Australia: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)

    16.3.5.5.3.1 Australia: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)

    16.3.5.6 Rest of Asia Pacific: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.3.5.6.1 Rest of Asia Pacific: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.3.5.6.2 Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)

    16.3.5.6.3 Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)

    16.3.5.6.3.1 Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019–2028 (USD Million)

    16.4 Middle East & Africa: Biopharmaceutical Tubing Market

    16.4.1 Overview

    16.4.2 Middle East & Africa: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (US$ Million)

    16.4.3 Middle East & Africa Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    16.4.4 Middle East & Africa Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    16.4.4.1 Middle East & Africa Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    16.4.5 Middle East & Africa: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)

    16.4.5.1 Saudi Arabia: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.4.5.1.1 Saudi Arabia: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.4.5.1.2 Saudi Arabia Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    16.4.5.1.3 Saudi Arabia Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    16.4.5.1.3.1 Saudi Arabia Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    16.4.5.2 UAE: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.4.5.2.1 UAE: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.4.5.2.2 UAE Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    16.4.5.2.3 UAE Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    16.4.5.2.3.1 UAE Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    16.4.5.3 South Africa: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.4.5.3.1 South Africa: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.4.5.3.2 South Africa Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    16.4.5.3.3 South Africa Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    16.4.5.3.3.1 South Africa Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    16.4.5.4 Rest of Middle East and Africa: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.4.5.4.1 Rest of Middle East and Africa: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.4.5.4.2 Rest of Middle East and Africa Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    16.4.5.4.3 Rest of Middle East and Africa Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)

    16.4.5.4.3.1 Rest of Middle East and Africa Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    16.5 South and Central America: Biopharmaceutical Tubing Market

    16.5.1 Overview

    16.5.2 South and Central America: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.5.3 South and Central America Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    16.5.4 South and Central America Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)

    16.5.4.1 South and Central America Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    16.5.5 South and Central America: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)

    16.5.5.1 Brazil: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.5.5.1.1 Brazil: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.5.5.1.2 Brazil Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    16.5.5.1.3 Brazil Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)

    16.5.5.1.3.1 Brazil Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    16.5.5.2 Argentina: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.5.5.2.1 Argentina: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.5.5.2.2 Argentina Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    16.5.5.2.3 Argentina Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)

    16.5.5.2.3.1 Argentina Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    16.5.5.3 Rest of South and Central America: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.5.5.3.1 Rest of South and Central America: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    16.5.5.3.2 Rest of South and Central America Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    16.5.5.3.3 Rest of South and Central America Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)

    16.5.5.3.3.1 Rest of South and Central America Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    17. Impact of COVID-19 Pandemic on Global Biopharmaceutical Tubing Market

    17.1 Global Impact of COVID-19

    17.2 North America: Impact Assessment of COVID-19 Pandemic

    17.3 Europe: Impact Assessment of COVID-19 Pandemic

    17.4 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

    17.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

    17.6 South and Central America: Impact Assessment of COVID-19 Pandemic

    18. Biopharmaceutical Tubing Market – Industry Landscape

    18.1 Overview

    18.2 Growth Strategies Done by the Companies in the Market, (%)

    18.3 Organic Developments

    18.3.1 Overview

    18.4 Inorganic Developments

    18.4.1 Overview

    19. Company Profiles

    19.1 W. L. Gore and Associates, Inc.

    19.1.1 Key Facts

    19.1.2 Business Description

    19.1.3 Products and Services

    19.1.4 Financial Overview

    19.1.5 SWOT Analysis

    19.1.6 Key Developments

    19.2 Saint-Gobain Sekurit

    19.2.1 Key Facts

    19.2.2 Business Description

    19.2.3 Products and Services

    19.2.4 Financial Overview

    19.2.5 SWOT Analysis

    19.2.6 Key Developments

    19.3 Freudenberg Group

    19.3.1 Key Facts

    19.3.2 Business Description

    19.3.3 Products and Services

    19.3.4 Financial Overview

    19.3.5 SWOT Analysis

    19.3.6 Key Developments

    19.4 RAUMEDIC AG

    19.4.1 Key Facts

    19.4.2 Business Description

    19.4.3 Products and Services

    19.4.4 Financial Overview

    19.4.5 SWOT Analysis

    19.4.6 Key Developments

    19.5 TEKNI-PLEX

    19.5.1 Key Facts

    19.5.2 Business Description

    19.5.3 Products and Services

    19.5.4 Financial Overview

    19.5.5 SWOT Analysis

    19.5.6 Key Developments

    19.6 NewAge Industries, Inc.

    19.6.1 Key Facts

    19.6.2 Business Description

    19.6.3 Products and Services

    19.6.4 Financial Overview

    19.6.5 SWOT Analysis

    19.6.6 Key Developments

    19.7 Optinova

    19.7.1 Key Facts

    19.7.2 Business Description

    19.7.3 Products and Services

    19.7.4 Financial Overview

    19.7.5 SWOT Analysis

    19.7.6 Key Developments

    19.8 Zeus Industrial Products, Inc.

    19.8.1 Key Facts

    19.8.2 Business Description

    19.8.3 Products and Services

    19.8.4 Financial Overview

    19.8.5 SWOT Analysis

    19.8.6 Key Developments

    19.9 NORDSON CORPORATION

    19.9.1 Key Facts

    19.9.2 Business Description

    19.9.3 Products and Services

    19.9.4 Financial Overview

    19.9.5 SWOT Analysis

    19.9.6 Key Developments

    19.10 DuPont de Nemours, Inc.

    19.10.1 Key Facts

    19.10.2 Business Description

    19.10.3 Products and Services

    19.10.4 Financial Overview

    19.10.5 SWOT Analysis

    19.10.6 Key Developments

    20. Company Profiles – For Supplier

    20.1 Specialty Silicone Products, Inc.

    20.1.1 Key Facts

    20.1.2 Business Description

    20.1.3 Products and Services

    20.1.4 Financial Overview

    20.2 Hoshine Silicon Industry Co., Ltd.

    20.2.1 Key Facts

    20.2.2 Business Description

    20.2.3 Products and Services

    20.2.4 Financial Overview

    20.3 Wacker Chemie AG

    20.3.1 Key Facts

    20.3.2 Business Description

    20.3.3 Products and Services

    20.3.4 Financial Overview

    20.4 Shin-Etsu Chemical Co., Ltd.

    20.4.1 Key Facts

    20.4.2 Business Description

    20.4.3 Products and Services

    20.4.4 Financial Overview

    20.5 Momentive

    20.5.1 Key Facts

    20.5.2 Business Description

    20.5.3 Products and Services

    20.5.4 Financial Overview

    20.6 Elkem ASA

    20.6.1 Key Facts

    20.6.2 Business Description

    20.6.3 Products and Services

    20.6.4 Financial Overview

    20.7 Avantor, Inc.

    20.7.1 Key Facts

    20.7.2 Business Description

    20.7.3 Products and Services

    20.7.4 Financial Overview

    21. Appendix

    21.1 About The Insight Partners

    21.2 Glossary of Terms

    LIST OF TABLES

    Table 1. Adoption of Alternative Materials

    Table 2. Global Biopharmaceutical Tubing Market, by Volume – Volume and Forecast to 2028 (Million Units)

    Table 3. North America Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 4. North America Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 5. North America Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 6. US Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 7. US Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 8. US Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 9. Canada Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 10. Canada Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 11. Canada Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 12. Mexico Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 13. Mexico Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 14. Mexico Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 15. Europe: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 16. Europe: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 17. Europe: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 18. Germany: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 19. Germany: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 20. Germany: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 21. France: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 22. France: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 23. France: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 24. UK: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 25. UK: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 26. UK: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 27. Italy: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 28. Italy: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 29. Italy: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 30. Spain: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 31. Spain: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 32. Spain: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 33. Rest of Europe: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 34. Rest of Europe: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 35. Rest of Europe: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 36. Asia Pacific: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 37. Asia Pacific: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 38. Asia Pacific: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 39. Japan: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 40. Japan: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 41. Japan: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 42. China: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 43. China: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 44. China: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 45. India: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 46. India: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 47. India: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 48. South Korea: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 49. South Korea: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 50. South Korea: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 51. Australia: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 52. Australia: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 53. Australia: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 54. Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 55. Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 56. Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 57. Middle East & Africa Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 58. Middle East & Africa Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 59. Middle East & Africa Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 60. Saudi Arabia Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 61. Saudi Arabia Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 62. Saudi Arabia Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 63. UAE Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 64. UAE Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 65. UAE Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 66. South Africa Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 67. South Africa Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 68. South Africa Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 69. Rest of Middle East and Africa Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 70. Rest of Middle East and Africa Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 71. Rest of Middle East and Africa Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 72. South and Central America Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 73. South and Central America Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 74. South and Central America Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 75. Brazil Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 76. Brazil Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 77. Brazil Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 78. Argentina Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 79. Argentina Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 80. Argentina Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 81. Rest of South and Central America Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)

    Table 82. Rest of South and Central America Biopharmaceutical Tubing Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 83. Rest of South and Central America Biopharmaceutical Tubing Market, by Pharmaceuticals– Revenue and Forecast to 2028 (USD Million)

    Table 84. Organic Developments Done By Companies

    Table 85. Inorganic Developments Done By Companies

    Table 86. Glossary of Terms, Biopharmaceutical Tubing Market

    LIST OF FIGURES

    Figure 1. Biopharmaceutical Tubing Market Segmentation

    Figure 2. Biopharmaceutical Tubing Market Segmentation, By Region

    Figure 3. Biopharmaceutical Tubing Market Overview

    Figure 4. Silicone Segment Held Largest Share of Biopharmaceutical Tubing Market

    Figure 5. APAC to Show Significant Growth During Forecast Period

    Figure 6. Biopharmaceutical Tubing Market, by Geography (US$ Million)

    Figure 7. Global Biopharmaceutical Tubing Market – Leading Country Markets (US$ Million)

    Figure 8. Global Biopharmaceutical Tubing Market, Industry Landscape

    Figure 9. North America PEST Analysis

    Figure 10. Europe PEST Analysis

    Figure 11. Asia Pacific PEST Analysis

    Figure 12. Middle East and Africa (MEA) PEST Analysis

    Figure 13. South and Central America (SCAM) PEST Analysis

    Figure 14. Price Fluctuation By Region

    Figure 15. Total Production Capacity of Major Players

    Figure 16. Global Biopharmaceutical Tubing Market – Revenue Forecast And Analysis – 2020- 2028

    Figure 17. Global Biopharmaceutical Tubing Market – By Geography Forecast and Analysis – 2020- 2028

    Figure 18. Market Positioning of Key Players In Global Biopharmaceutical Tubing Market

    Figure 19. Biopharmaceutical Tubing Market Revenue Share, by Type (2021 and 2028)

    Figure 20. Plastic: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 21. Metal: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 22. Silicone: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 23. Biopharmaceutical Tubing Market Revenue Share, by Application (2021 and 2028)

    Figure 24. Pharmaceutical: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 25. Medical Devices: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 26. Research and Development: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 27. Others: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 28. North America: Biopharmaceutical Tubing Market, by Key Country – Revenue (2021) (USD Million)

    Figure 29. North America Biopharmaceutical Tubing Market Revenue and Forecast to 2028 (USD Million)

    Figure 30. North America: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)

    Figure 31. US: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 32. Canada: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 33. Mexico: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 34. Europe: Biopharmaceutical Tubing Market, by Key Country – Revenue (2021) (USD Million)

    Figure 35. Europe: Biopharmaceutical Tubing Market Revenue and Forecast to 2028 (USD Million)

    Figure 36. Europe: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)

    Figure 37. Germany: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 38. France: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 39. UK: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 40. Italy: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 41. Spain: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 42. Rest of Europe: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 43. Asia Pacific: Biopharmaceutical Tubing Market, by Key Country – Revenue (2021) (USD Million)

    Figure 44. Asia Pacific: Biopharmaceutical Tubing Market Revenue and Forecast to 2028 (USD Million)

    Figure 45. Asia Pacific: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)

    Figure 46. Japan: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 47. China: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 48. India: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 49. South Korea: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 50. Australia: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 51. Rest of Asia Pacific: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 52. Middle East & Africa: Biopharmaceutical Tubing Market, by Key Country – Revenue (2021) (USD Million)

    Figure 53. Middle East & Africa Biopharmaceutical Tubing Market Revenue and Forecast to 2028 (USD Million)

    Figure 54. Middle East & Africa: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)

    Figure 55. Saudi Arabia: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 56. UAE: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 57. South Africa: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 58. Rest of Middle East and Africa: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 59. South and Central America: Biopharmaceutical Tubing Market, by Key Country – Revenue (2021) (USD Million)

    Figure 60. South and Central America Biopharmaceutical Tubing Market Revenue and Forecast to 2028 (USD Million)

    Figure 61. South and Central America: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)

    Figure 62. Brazil: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 63. Argentina: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 64. Rest of South and Central America: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 65. Impact of COVID-19 Pandemic on Biopharmaceutical Tubing Market in North American Countries

    Figure 66. Impact of COVID-19 Pandemic on Biopharmaceutical Tubing Market in European Countries

    Figure 67. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets

    Figure 68. Impact of COVID-19 Pandemic on Biopharmaceutical Tubing Market in Middle East and Africa

    Figure 69. Impact of COVID-19 Pandemic on Biopharmaceutical Tubing Market in South and Central America

    Figure 70. Growth Strategies Done by the Companies in the Market, (%)

    The List of Companies - Biopharmaceutical Tubing Market

    1. W. L. Gore and Associates, Inc.
    2. Saint-Gobain Sekurit
    3. Freudenberg Group
    4. RAUMEDIC AG
    5. TEKNI-PLEX
    6. NewAge Industries, Inc.
    7. Optinova
    8. Zeus Industrial Products, Inc.
    9. NORDSON CORPORATION
    10. DuPont de Nemours, Inc.
    11. Specialty Silicone Products, Inc.
    12. Hoshine Silicon Industry Co., Ltd.
    13. Wacker Chemie AG
    14. Shin-Etsu Chemical Co., Ltd.
    15. Momentive
    16. Elkem ASA
    17. Wacker Chemie AG   
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the biopharmaceutical tubing market. 
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in the global biopharmaceutical tubing market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
    TIPRE00008648
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Have a question?

    Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


    Speak To Analyst
    Pricing
    • $3000
    • $4550
    • $6550
    • $8550
        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount